tranexamic acid has been researched along with Insulin Resistance in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that in hemorrhagic shock elevated microvascular extracellular digestive enzyme activity causes insulin receptor dysfunction, hyperglycemia, and reduced ability to regulate blood glucose values." | 1.40 | Pancreatic digestive enzyme blockade in the small intestine prevents insulin resistance in hemorrhagic shock. ( DeLano, FA; Schmid-Schönbein, GW, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeLano, FA | 1 |
| Schmid-Schönbein, GW | 1 |
1 other study available for tranexamic acid and Insulin Resistance
| Article | Year |
|---|---|
Pancreatic digestive enzyme blockade in the small intestine prevents insulin resistance in hemorrhagic shock.
Topics: Animals; Blood Glucose; Glucose Tolerance Test; Insulin Resistance; Intestine, Small; Male; Pancreas | 2014 |